Online citations, reference lists, and bibliographies.
← Back to Search

A Trial Of A Single-tablet Regimen Of Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate For The Initial Treatment Of Human Immunodeficiency Virus Type 2 Infection In A Resource-limited Setting: 48-Week Results From Senegal, West Africa

Selly Ba, Dana N Raugi, Robert A Smith, Fatima Sall, Khadim Faye, Stephen E Hawes, Papa Salif Sow, Moussa Seydi, Geoffrey S Gottlieb, Fatou Traore, Marie Pierre Sy, Bintou Diaw, Mbaye Ndoye, Amadou Bale Diop, Marianne Fadam Diome, Alassane Niang, Jean Jacques Malomar, ElHadji Ibrahima Sall, Ousseynou Cisse, Ibrahima Tito Tamba, Jean Philippe Diatta, Jacques Sambou, Raphael Bakhoum, Juliette Gomis, Noelle Benzekri, John Lin, Nancy Kiviat, Sally Leong, Sara Masoum, Vincent Wu, Carol Gallardo, Eleanor Espinosa, Ming Chang, Bob Coombs,

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Our trial of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate in antiretroviral therapy–naive HIV-2–infected individuals for 48 weeks, in a resource-limited setting, demonstrated favorable immunovirologic outcomes and was well tolerated.